Advertisement

Ceftriaxone Sodium Injection

[16 June 2016]

Products Affected - Description

Ceftriaxone injection, Apotex
1 gram, vial, 10 count (NDC 60505-0752-04)
2 gram, vial, 10 count (NDC 60505-0753-04)
10 gram, vial, 1 count (NDC 60505-0679-05)
250 mg, vial, 10 count (NDC 60505-0750-04)
500 mg, vial, 10 count (NDC 60505-0751-00)
 
Ceftriaxone injection, BBraun
1 gram/50 mL, premixed bag, 24 count (NDC 00264-3153-11)
2 gram/50 mL, premixed bag, 24 count (NDC 00264-3155-11)
 
Ceftriaxone injection, West-Ward
1 gram, vial, 25 count (NDC 00143-9857-25)
2 gram, vial, 25 count (NDC 00143-9856-25)
250 mg, vial, 25 count (NDC 00143-9859-25)
 
Ceftriaxone injection, Wockhardt USA
1 gram, vial, 10 count (NDC 64679-0983-02)
2 gram, vial, 10 count (NDC 64679-0703-01)
250 mg, vial, 10 count (NDC 64679-0701-02)
500 mg, vial, 10 count (NDC 64679-0702-02)

Reason for the Shortage

  • Fresenius Kabi states the reason for the shortage is increased demand.
  • Hospira states the reason for the shortage was manufacturing delay.
  • Sagent states the reason for the shortage is increased demand.
  • Sandoz cannot provide a reason for the shortage.
  • WG Critical Care states the reason for the shortage is increased demand.

Available Products

Ceftriaxone injection, Baxter
1 gram/50 mL, premixed bag, 24 count (NDC 00338-5002-41)
2 gram/50 mL, premixed bag, 24 count (NDC 00338-5003-41)
 
Ceftriaxone injection, Fresenius Kabi
1 gram, vial, 25 count (NDC 63323-0346-10)
2 gram, vial, 10 count (NDC 63323-0347-20)
10 gram, vial, 1 count (NDC 63323-0348-61)
250 mg, vial, 25 count (NDC 63323-0344-10)
500 mg, vial, 25 count (NDC 63323-0345-10)
 
Ceftriaxone injection, Hospira
1 gram, ADD-Vantage vial, 10 count (NDC 00409-7333-04)
1 gram, vial, 10 count (NDC 00409-7332-01)
2 gram, ADD-Vantage vial, 10 count (NDC 00409-7336-04)
2 gram, vial, 10 count (NDC 00409-7335-03)
10 gram, vial, 1 count (NDC 00409-7334-10)
250 mg, vial, 10 count (NDC 00409-7337-01)
500 mg, vial, 10 count (NDC 00409-7338-01)
 
Ceftriaxone injection, Lupin
1 gram, vial, 10 count (NDC 68180-0633-10)
2 gram, vial, 10 count (NDC 68180-0644-10)
250 mg, vial, 10 count (NDC 68180-0611-10)
500 mg, vial, 10 count (NDC 68180-0622-10)
 
Ceftriaxone injection, Sagent
1 gram, vial, 25 count (NDC 25021-0106-10)
2 gram, vial, 25 count (NDC 25021-0107-20)
10 gram, vial, 1 count (NDC 25021-0108-99)
500 mg, vial, 25 count (NDC 25021-0105-10)
 
Ceftriaxone injection, Samson Medical Technologies
100 gram, SmartPak bulk vial, 1 count (NDC 66288-6100-01)
 
Ceftriaxone injection, Sandoz
1 gram, vial, 10 count (NDC 00781-3208-95)
2 gram, vial, 10 count (NDC 00781-3209-95)
10 gram, vial, 1 count (NDC 00781-3210-46)
250 mg, vial, 10 count (NDC 00781-3206-95)
500 mg, vial, 10 count (NDC 00781-3207-95)
 
Ceftriaxone injection, WG Critical Care
1 gram, vial, 25 count (NDC 44567-0701-25)
2 gram, vial, 25 count (NDC 44567-0702-25)
10 gram, vial, 1 count (NDC 44567-0703-01)
 
Ceftriaxone injection, West-Ward
500 mg, vial, 25 count (NDC 00143-9858-25)

Estimated Resupply Dates

  • Apotex has ceftriaxone 1 gram vials on back order and the company estimates a release date of mid-July 2016. The 250 mg, 500 mg, 2 gram, and 10 gram vials are back order and the company cannot estimate a release date.
  • BBraun has both ceftriaxone presentations on allocation.
  • West-Ward has ceftriaxone 1 gram vials on back order and the company estimates a release date in June 2016. The 2 gram vials are on allocation with weekly releases. Ceftriaxone 250 mg vials are on back order and the company estimates a release date of late-June to July 2016.
  • Wockhardt has ceftriaxone 250 mg, 500 mg, 1 gram, and 2 gram vials on back order and the company estimates a release date of September 2016 for the 1 gram and 2 gram vials and cannot estimate a release date for the 250 mg and 500 mg vials.

Related Shortages

Updated

June 16, May 31, 13 and 3, April 13 and 6, March 23 and 3, February 26, January 6, 2016; December 17, November 30 and 16, October 5, September 9, August 5, July 16 and 10, June 23, 22 and 5, May 8, April 20, 16 and 8, March 10, February 20 and 3, January 9, 2015; December 12, November 26, 21, 19, 7 and 4, October 9, September 25, 15 and 4, August 21 and 6, July 21, 14 and 9, June 17 and 3, May 29, 14, 8 and 1, 2014, University of Utah, Drug Information Service. Copyright 2016, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins

Advocacy Activity
Get the latest updates on ASHP's advocacy activity on drug shortages.
Advertisement
ASHP Product Listing